Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vascular shutdown refers to the process of blocking or reducing blood flow through blood vessels, often used in therapeutic contexts to inhibit tumor growth by depriving cancer cells of oxygen and nutrients. It can be achieved through various methods, including ultrasound therapy with microbubbles, photodynamic therapy, and radiation therapy. This process is not a specific molecular target but rather a therapeutic strategy involving multiple biological pathways and mechanisms.
Involves damage to endothelial cells, leading to platelet aggregation and clotting, often through mechanisms like cavitation in ultrasound therapy or activation of specific pathways in photodynamic therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular Shutdown.